Cargando…

Plasma Levels of Oxidative Stress Markers, before and after BoNT/A Treatment, in Chronic Migraine

The pathophysiological mechanisms of migraine transformation are debated. Modifications of plasma oxidative stress biomarkers have been described in chronic migraine. OnabotulintoxinA (BoNT/A) treatment, approved for chronic migraine prophylaxis, possibly reduces pain neurotransmitters release and o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dini, Elisa, Mazzucchi, Sonia, De Luca, Ciro, Cafalli, Martina, Chico, Lucia, Lo Gerfo, Annalisa, Siciliano, Gabriele, Bonuccelli, Ubaldo, Baldacci, Filippo, Gori, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832499/ https://www.ncbi.nlm.nih.gov/pubmed/31635021 http://dx.doi.org/10.3390/toxins11100608

Ejemplares similares

P058. Refractory chronic migraine, fatigue and OnabotulinumtoxinA: a clinic setting experience
por: Baldacci, Filippo, et al.
Publicado: (2015)

P041. Analysis of body mass index, psychiatric comorbidity, sleep-wake pattern and occurrence of fatigue in episodic and chronic migraine patients
por: Lucchesi, Cinzia, et al.
Publicado: (2015)

Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease
por: De Luca, Ciro, et al.
Publicado: (2021)

Navigating the Complexities Involving the Identification of Botulinum Neurotoxins (BoNTs) and the Taxonomy of BoNT-Producing Clostridia
por: Smith, Theresa J., et al.
Publicado: (2023)

Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches
por: Martinelli, Daniele, et al.
Publicado: (2023)

Mucosal Targeting of a BoNT/A Subunit Vaccine Adjuvanted with a Mast Cell Activator Enhances Induction of BoNT/A Neutralizing Antibodies in Rabbits
por: Staats, Herman F., et al.
Publicado: (2011)

The Effects of Intradetrusor BoNT-A Injections on Vesicoureteral Reflux in Children With Myelodysplasia
por: Toprak, Tuncay, et al.
Publicado: (2019)

Exploring the genetic background of the botulism neurotoxin BoNT/B2 in Spain
por: Valdezate, Sylvia, et al.
Publicado: (2023)

BoNT/A in the Urinary Bladder—More to the Story than Silencing of Cholinergic Nerves
por: Ibrahim, Hodan, et al.
Publicado: (2022)

A novel RRGW derived peptide is a promising inhibitor of BoNT/A
por: Ma, Wantong, et al.
Publicado: (2023)

CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
por: De Luca, Ciro, et al.
Publicado: (2021)

Small-Molecule Quinolinol Inhibitor Identified Provides Protection against BoNT/A in Mice
por: Singh, Padma, et al.
Publicado: (2012)

Probing BoNT/A Protease Exosites: Implications for Inhibitor Design and Light Chain Longevity
por: Xue, Song, et al.
Publicado: (2014)

Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT)
por: Bai, Lili, et al.
Publicado: (2018)

Botulinum neurotoxin (BoNT) treatment in functional movement disorders: long-term follow-up
por: Dreissen, Yasmine EM, et al.
Publicado: (2020)

A Three-Monoclonal Antibody Combination Potently Neutralizes BoNT/G Toxin in Mice
por: Fan, Yongfeng, et al.
Publicado: (2023)

Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
por: Webb, Robert P., et al.
Publicado: (2017)

Reduction in expenditures on analgesics during one year of treatment of chronic tension headache with BoNT-A
por: Coloprisco, Gabriella, et al.
Publicado: (2003)

Hypersensitive Detection and Quantitation of BoNT/A by IgY Antibody against Substrate Linear-Peptide
por: Li, Tao, et al.
Publicado: (2013)

Retraction: Small-Molecule Quinolinol Inhibitor Identified Provides Protection against BoNT/A in Mice
por: Singh, Padma, et al.
Publicado: (2013)

Designing and analyzing the structure of Tat-BoNT/A(1-448) fusion protein: An in silico approach
por: Amani, Jafar, et al.
Publicado: (2014)

The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA
por: Fan, Yongfeng, et al.
Publicado: (2019)

Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury
por: Adler, Michael, et al.
Publicado: (2022)

Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine
por: Lou, Jianlong, et al.
Publicado: (2018)

Effect of BoNT/A in the Surface Electromyographic Characteristics of the Pelvic Floor Muscles for the Treatment of Chronic Pelvic Pain
por: Albaladejo-Belmonte, Monica, et al.
Publicado: (2021)

BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional Study
por: Maignel, Jacquie, et al.
Publicado: (2022)

Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?
por: Baricich, Alessio, et al.
Publicado: (2023)

The Efficacy of Transvaginal Ultrasound-Guided BoNT-A External Sphincter Injection in Female Patients with Underactive Bladder
por: Tsai, Cheng-Yen, et al.
Publicado: (2023)

Further optimization of peptide substrate enhanced assay performance for BoNT/A detection by MALDI-TOF mass spectrometry
por: Wang, Dongxia, et al.
Publicado: (2017)

Human-Relevant Sensitivity of iPSC-Derived Human Motor Neurons to BoNT/A1 and B1
por: Schenke, Maren, et al.
Publicado: (2021)

BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach
por: Baricich, Alessio, et al.
Publicado: (2021)

Subcutaneous BoNT/A Injection for Intractable Pain and Disability in Complex Regional Pain Syndrome: A Case Report
por: Tereshko, Yan, et al.
Publicado: (2022)

Comparison of botulinum toxin (BoNT) injection and lateral internal sphincterotomy (redo-LIS) for recurrent anal fissure treatment
por: Alyanak, Ahmet, et al.
Publicado: (2022)

Multicolor fluorescence activated cell sorting to generate humanized monoclonal antibody binding seven subtypes of BoNT/F
por: Fan, Yongfeng, et al.
Publicado: (2022)

Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis
por: Cinone, Nicoletta, et al.
Publicado: (2022)

Outbreaks of iatrogenic botulism in Europe: Combating off-label medical use of Botulinum Neurotoxin (BoNT) in bariatric procedures
por: Jain, Nityanand, et al.
Publicado: (2023)

Alpha-Latrotoxin Rescues SNAP-25 from BoNT/A-Mediated Proteolysis in Embryonic Stem Cell-Derived Neurons
por: Mesngon, Mariano, et al.
Publicado: (2011)

Anti-Inflammatory Effects of BoNT/A Against Complete Freund’s Adjuvant-Induced Arthritis Pain in Rats: Transcriptome Analysis
por: Li, Xinhe, et al.
Publicado: (2021)

α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise
por: Daniele, Simona, et al.
Publicado: (2018)

Impact of ApoE Polymorphism and Physical Activity on Plasma Antioxidant Capability and Erythrocyte Membranes
por: Piccarducci, Rebecca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l034kkghhog6s92dfqoeifetmg